Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Encephalitis, Tick-Borne | 2 | 2017 | 86 | 1.28 | Why? |
| Encephalitis Viruses, Tick-Borne | 1 | 2017 | 100 | 0.65 | Why? |
| Enzyme-Linked Immunosorbent Assay | 4 | 2020 | 7868 | 0.59 | Why? |
| Serologic Tests | 4 | 2021 | 4359 | 0.38 | Why? |
| Immunoglobulin M | 4 | 2021 | 9091 | 0.33 | Why? |
| Immunoassay | 2 | 2020 | 4485 | 0.33 | Why? |
| BK Virus | 2 | 2018 | 135 | 0.32 | Why? |
| Polyomavirus Infections | 2 | 2018 | 156 | 0.31 | Why? |
| Antibodies, Viral | 10 | 2021 | 51949 | 0.29 | Why? |
| Immunoglobulin G | 6 | 2021 | 21571 | 0.23 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.20 | Why? |
| Allografts | 2 | 2020 | 761 | 0.19 | Why? |
| Polyomavirus | 1 | 2018 | 37 | 0.18 | Why? |
| Human T-lymphotropic virus 2 | 1 | 2017 | 8 | 0.18 | Why? |
| Staphylococcus lugdunensis | 1 | 2017 | 14 | 0.17 | Why? |
| France | 8 | 2021 | 12074 | 0.17 | Why? |
| Kidney Transplantation | 4 | 2021 | 5397 | 0.17 | Why? |
| HTLV-I Infections | 1 | 2017 | 54 | 0.17 | Why? |
| Tumor Virus Infections | 1 | 2017 | 127 | 0.16 | Why? |
| Pharmacy Residencies | 1 | 2017 | 59 | 0.16 | Why? |
| Medical Laboratory Science | 1 | 2017 | 122 | 0.15 | Why? |
| Hepatitis B Surface Antigens | 1 | 2017 | 305 | 0.15 | Why? |
| Antibodies, Bacterial | 1 | 2017 | 510 | 0.13 | Why? |
| Leukemia, Myeloid, Acute | 1 | 2020 | 676 | 0.13 | Why? |
| Sex Characteristics | 1 | 2021 | 1120 | 0.13 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.13 | Why? |
| Rituximab | 1 | 2021 | 1096 | 0.12 | Why? |
| Virology | 1 | 2017 | 489 | 0.12 | Why? |
| Antibodies, Neutralizing | 6 | 2021 | 25288 | 0.12 | Why? |
| Problem-Based Learning | 1 | 2017 | 363 | 0.12 | Why? |
| Sensitivity and Specificity | 4 | 2021 | 22971 | 0.11 | Why? |
| Immune Evasion | 1 | 2021 | 2081 | 0.11 | Why? |
| DNA, Viral | 2 | 2017 | 2521 | 0.10 | Why? |
| Convalescence | 1 | 2021 | 2829 | 0.10 | Why? |
| Hepatitis B virus | 1 | 2017 | 882 | 0.10 | Why? |
| Hepatitis B | 1 | 2017 | 888 | 0.09 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.09 | Why? |
| Personal Satisfaction | 1 | 2017 | 1243 | 0.08 | Why? |
| Autoimmune Diseases | 1 | 2021 | 1996 | 0.08 | Why? |
| Reagent Kits, Diagnostic | 1 | 2017 | 2149 | 0.08 | Why? |
| Viral Load | 4 | 2021 | 15850 | 0.08 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.08 | Why? |
| Family | 1 | 2020 | 2909 | 0.08 | Why? |
| Kidney Diseases | 1 | 2017 | 1434 | 0.08 | Why? |
| Myocarditis | 1 | 2021 | 2731 | 0.07 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.07 | Why? |
| Aged, 80 and over | 6 | 2021 | 88759 | 0.07 | Why? |
| Viral Envelope Proteins | 1 | 2017 | 3539 | 0.07 | Why? |
| Seasons | 1 | 2017 | 4071 | 0.07 | Why? |
| Immunologic Factors | 1 | 2021 | 4206 | 0.07 | Why? |
| Kinetics | 2 | 2021 | 3238 | 0.06 | Why? |
| T-Lymphocytes | 1 | 2020 | 6670 | 0.06 | Why? |
| Male | 15 | 2021 | 367725 | 0.06 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.06 | Why? |
| Young Adult | 4 | 2021 | 93724 | 0.05 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.05 | Why? |
| Antigens, CD20 | 1 | 2021 | 105 | 0.05 | Why? |
| Humans | 22 | 2021 | 930598 | 0.05 | Why? |
| Adult | 9 | 2021 | 244371 | 0.05 | Why? |
| Aged | 8 | 2021 | 215776 | 0.05 | Why? |
| Female | 12 | 2021 | 380317 | 0.05 | Why? |
| Gadolinium | 1 | 2021 | 318 | 0.05 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.05 | Why? |
| Prospective Studies | 3 | 2021 | 43301 | 0.05 | Why? |
| Genomic Islands | 1 | 2017 | 26 | 0.04 | Why? |
| Prophages | 1 | 2017 | 11 | 0.04 | Why? |
| Interspersed Repetitive Sequences | 1 | 2017 | 29 | 0.04 | Why? |
| Antibody Formation | 2 | 2021 | 4038 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Human T-lymphotropic virus 1 | 1 | 2017 | 52 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
| Antibody Specificity | 1 | 2021 | 1328 | 0.04 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2021 | 37182 | 0.04 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.04 | Why? |
| Internship and Residency | 1 | 2017 | 4987 | 0.04 | Why? |
| RNA, Viral | 2 | 2020 | 32276 | 0.04 | Why? |
| Serum | 1 | 2017 | 294 | 0.04 | Why? |
| Incidence | 1 | 2017 | 25622 | 0.04 | Why? |
| Genotype | 2 | 2017 | 4697 | 0.04 | Why? |
| Contrast Media | 1 | 2021 | 1011 | 0.04 | Why? |
| Molecular Sequence Annotation | 1 | 2017 | 478 | 0.04 | Why? |
| Urine | 1 | 2017 | 469 | 0.04 | Why? |
| Transplant Recipients | 2 | 2021 | 4982 | 0.03 | Why? |
| Virulence Factors | 1 | 2017 | 338 | 0.03 | Why? |
| Immunologic Tests | 1 | 2017 | 445 | 0.03 | Why? |
| Longitudinal Studies | 2 | 2021 | 9893 | 0.03 | Why? |
| Students, Pharmacy | 1 | 2017 | 174 | 0.03 | Why? |
| Genome, Bacterial | 1 | 2017 | 446 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.03 | Why? |
| Sequence Deletion | 1 | 2017 | 674 | 0.03 | Why? |
| Follow-Up Studies | 2 | 2021 | 17020 | 0.03 | Why? |
| Ventricular Function, Left | 1 | 2021 | 1555 | 0.03 | Why? |
| False Positive Reactions | 1 | 2017 | 1338 | 0.03 | Why? |
| Stroke Volume | 1 | 2021 | 2153 | 0.03 | Why? |
| Phosphoproteins | 1 | 2021 | 4346 | 0.03 | Why? |
| Seroconversion | 1 | 2020 | 2515 | 0.03 | Why? |
| Viremia | 1 | 2017 | 1020 | 0.03 | Why? |
| Recombination, Genetic | 1 | 2017 | 1265 | 0.03 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.02 | Why? |
| Epitopes | 1 | 2021 | 4113 | 0.02 | Why? |
| Child | 1 | 2017 | 70012 | 0.02 | Why? |
| HEK293 Cells | 1 | 2021 | 8394 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.02 | Why? |
| Neutralization Tests | 1 | 2021 | 6698 | 0.02 | Why? |
| Staphylococcal Infections | 1 | 2017 | 1099 | 0.02 | Why? |
| Immunity, Cellular | 1 | 2020 | 3614 | 0.02 | Why? |
| RNA, Messenger | 1 | 2021 | 5131 | 0.02 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 2426 | 0.02 | Why? |
| Survival Rate | 1 | 2020 | 9206 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.02 | Why? |
| Retrospective Studies | 1 | 2017 | 105322 | 0.02 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.02 | Why? |
| Mortality | 1 | 2021 | 7132 | 0.02 | Why? |
| India | 1 | 2021 | 11875 | 0.02 | Why? |
| Blood Donors | 1 | 2017 | 2956 | 0.02 | Why? |
| Immunosuppressive Agents | 1 | 2021 | 6331 | 0.01 | Why? |
| Clinical Competence | 1 | 2017 | 3263 | 0.01 | Why? |
| Case-Control Studies | 1 | 2020 | 17671 | 0.01 | Why? |
| Nasopharynx | 1 | 2020 | 10224 | 0.01 | Why? |
| Health Personnel | 2 | 2021 | 29646 | 0.01 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 9335 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Students, Medical | 1 | 2017 | 4032 | 0.01 | Why? |
| Coinfection | 1 | 2017 | 6820 | 0.01 | Why? |
| Mutation | 1 | 2017 | 12376 | 0.01 | Why? |
| Virus Replication | 1 | 2017 | 14331 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Risk Assessment | 1 | 2017 | 25439 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| HIV Infections | 1 | 2017 | 11620 | 0.01 | Why? |
| Risk Factors | 1 | 2021 | 71621 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.01 | Why? |